Critical Comparison: Vascular Solutions (VASC) vs. Alphatec Holdings (NASDAQ:ATEC)
Vascular Solutions (NASDAQ: VASC) and Alphatec Holdings (NASDAQ:ATEC) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitabiliy.
Insider & Institutional Ownership
80.2% of Vascular Solutions shares are owned by institutional investors. Comparatively, 20.7% of Alphatec Holdings shares are owned by institutional investors. 6.9% of Vascular Solutions shares are owned by insiders. Comparatively, 23.6% of Alphatec Holdings shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares Vascular Solutions and Alphatec Holdings’ top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
Alphatec Holdings is trading at a lower price-to-earnings ratio than Vascular Solutions, indicating that it is currently the more affordable of the two stocks.
This table compares Vascular Solutions and Alphatec Holdings’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current ratings and recommmendations for Vascular Solutions and Alphatec Holdings, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Vascular Solutions presently has a consensus target price of $55.50, indicating a potential downside of 0.89%. Given Vascular Solutions’ higher probable upside, equities research analysts clearly believe Vascular Solutions is more favorable than Alphatec Holdings.
Volatility & Risk
Vascular Solutions has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. Comparatively, Alphatec Holdings has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500.
Vascular Solutions beats Alphatec Holdings on 6 of the 8 factors compared between the two stocks.
Vascular Solutions Company Profile
Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company’s product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.
Alphatec Holdings Company Profile
Alphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its products include Cervical and Cervico-Thoracic Products, which include Trestle Luxe Anterior Cervical Plate System and Pegasus Anchored Cervical Interbody; Thoracolumbar Fixation Products, which include Arsenal Degenerative System and OsseoScrew Spinal Fixation System; Spinal Spacers, which include Battalion Universal Spacer System and Alphatec Solus Locking ALIF Spinal Spacer; minimally invasive surgery Products, which include Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System, and Biologics, which include Neocore Osteoconductive Matrix.
Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.